OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling
Cristina Panuzzo, Aleksandar Jovanovski, Muhammad Shahzad Ali, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 483-483
Open Access | Times Cited: 13

Showing 13 citing articles:

Blockade of TIGAR prevents CD8+ T cell dysfunction and elicits anti-AML immunity
Jialin Cui, Wenjie Liu, Shiyang Zhong, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access

Droplet digital PCR for sensitive relapse detection in acute myeloid leukaemia patients transplanted by reduced intensity conditioning
J. Grønlund, Christopher Veigaard, Caroline Juhl‐Christensen, et al.
European Journal Of Haematology (2024) Vol. 112, Iss. 4, pp. 601-610
Open Access | Times Cited: 3

MRD in ALL: Optimization and Innovations
Eric Pierce, Benjamin Mautner, Joseph F. Mort, et al.
Current Hematologic Malignancy Reports (2022) Vol. 17, Iss. 4, pp. 69-81
Closed Access | Times Cited: 10

Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection
Kritika Srinivasan Rajsri, Nainita Roy, Sohini Chakraborty
Cancers (2023) Vol. 15, Iss. 10, pp. 2866-2866
Open Access | Times Cited: 6

Development of a Next-generation Sequencing-based Gene Panel Test to Detect Measurable Residual Disease in Acute Myeloid Leukemia
Jin Ju Kim, Ji Eun Jang, Hyeon Ah Lee, et al.
Annals of Laboratory Medicine (2023) Vol. 43, Iss. 4, pp. 328-336
Open Access | Times Cited: 5

Evaluation of MicroRNA as Minimal Residual Disease in Leukemia: Diagnostic and Prognostic Approach: A Review
Bahareh Shateri Amiri, Neda Sabernia, Behdokht Abouali, et al.
Iranian Journal of Public Health (2023)
Open Access | Times Cited: 5

Ultrasensitive quantitation of FLT3-ITD mutation in patients with acute myeloid leukemia using ddPCR
Amir Asri kojabad, Rouzbeh Chegeni, Shaharbano Rostami, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6097-6105
Closed Access | Times Cited: 2

Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia
Tali Azenkot, Brian A. Jonas
Cancers (2022) Vol. 14, Iss. 15, pp. 3634-3634
Open Access | Times Cited: 4

Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?
Caterina Alati, Martina Pitea, Maria Caterina Micò, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 8, pp. 515-525
Closed Access

Molecular MRD Assessment in Acute Myeloid Leukemias
Shivangi Harankhedkar, Nikhil Patkar
Indian Journal of Medical and Paediatric Oncology (2023) Vol. 44, Iss. 06, pp. 566-577
Open Access | Times Cited: 1

Measurable Residual Disease Testing Using Next-Generation Sequencing in Acute Myeloid Leukemia
Seon Young Kim, Hee Jin Huh
Annals of Laboratory Medicine (2023) Vol. 43, Iss. 4, pp. 323-324
Open Access

Page 1

Scroll to top